Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-22-011263
Filing Date
2022-08-15
Accepted
2022-08-15 08:01:12
Documents
58
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q aclarion_10q.htm   iXBRL 10-Q 968672
2 CERTIFICATION aclarion_ex311.htm EX-31.1 12440
3 CERTIFICATION aclarion_ex312.htm EX-31.2 12578
4 CERTIFICATION aclarion_ex321.htm EX-32.1 4287
5 CERTIFICATION aclarion_ex322.htm EX-32.2 4055
  Complete submission text file 0001654954-22-011263.txt   4138195

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA aclarion-20220630.xsd EX-101.SCH 48410
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE aclarion-20220630_lab.xml EX-101.LAB 257433
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aclarion-20220630_cal.xml EX-101.CAL 38448
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aclarion-20220630_pre.xml EX-101.PRE 219350
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aclarion-20220630_def.xml EX-101.DEF 136531
52 EXTRACTED XBRL INSTANCE DOCUMENT aclarion_10q_htm.xml XML 558529
Mailing Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021
Business Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021 833 275 2266
Aclarion, Inc. (Filer) CIK: 0001635077 (see all company filings)

EIN.: 473324725 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41358 | Film No.: 221162433
SIC: 8071 Services-Medical Laboratories